Moderna (MRNA) CEO Issues Update to Shareholders

Go back to Moderna (MRNA) CEO Issues Update to Shareholders

Moderna to Provide Business and Pipeline Updates at the 2023 J.P. Morgan Healthcare Conference

January 3, 2023 7:01 AM UTC

CAMBRIDGE, MA / ACCESSWIRE / January 3, 2023 / Moderna, Inc. (NASDAQ: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that CEO Stphane Bancel will present an update on the Company and its pipeline of mRNA development programs at the 41st annual J.P. Morgan Healthcare Conference on Monday, January 9th at 5:15 p.m. ET.

A live webcast of the presentation will be... More